Advertisement
Logos Biosystems
Logos Biosystems

The Scientist

» cancer and disease/medicine

Most Recent

image: More Lab-Made Nucleotides

More Lab-Made Nucleotides

By | June 8, 2015

Artificial bases that act like the real deal can be designed to bind specifically to tumor cells.

0 Comments

image: Drug for Low Sex Drive in Women?

Drug for Low Sex Drive in Women?

By | June 8, 2015

A federal advisory panel supports the US Food and Drug Administration’s approval of the first drug for female sexual dysfunction.

1 Comment

image: The Roots of Schizophrenia

The Roots of Schizophrenia

By | June 4, 2015

Researchers link disease-associated mutations to excitatory and inhibitory signaling in the brain.

0 Comments

image: NCI Gets Personal

NCI Gets Personal

By | June 2, 2015

The National Cancer Institute is launching a Phase 2 trial matching patients with specific mutations to drugs tailored to those genetic changes.

0 Comments

image: Clinical Matchmaker

Clinical Matchmaker

By | June 1, 2015

Enrolling the right patient population could be key to a successful clinical trial.

0 Comments

image: Resistance Fighter

Resistance Fighter

By | June 1, 2015

Stuart Levy has spent a lifetime studying mechanisms of antibiotic resistance and crusading to abolish the use of antibiotics in animal feed.

0 Comments

image: Viral Immunotherapy for Melanoma

Viral Immunotherapy for Melanoma

By | May 28, 2015

Phase 3 data from a clinical trial show a positive response to a melanoma treatment based on a modified herpesvirus.

0 Comments

image: Cancer-Driving Mutations Common in Normal Skin Cells

Cancer-Driving Mutations Common in Normal Skin Cells

By | May 21, 2015

A deep-sequencing analysis reveals that non-malignant skin cells harbor many more cancer-driving mutations than previously expected. 

0 Comments

image: Clinical Epidemiology Pioneer Dies

Clinical Epidemiology Pioneer Dies

By | May 18, 2015

Evidence-based medicine advocate David Sackett has passed away at age 80.

0 Comments

Researchers develop a CRISPR-based, two-phage system that sensitizes resistant bacteria to antibiotics and selectively kills any remaining drug-resistant bugs. 

0 Comments

Popular Now

  1. The Mycobiome
    Features The Mycobiome

    The largely overlooked resident fungal community plays a critical role in human health and disease.

  2. Antibody Alternatives
    Features Antibody Alternatives

    Nucleic acid aptamers and protein scaffolds could change the way researchers study biological processes and treat disease.

  3. Holding Their Ground
    Features Holding Their Ground

    To protect the global food supply, scientists want to understand—and enhance—plants’ natural resistance to pathogens.

  4. Circadian Clock and Aging
    Daily News Circadian Clock and Aging

    Whether a critical circadian clock gene is deleted before or after birth impacts the observed aging-related effects in mice.

Advertisement
Bio-Rad
Bio-Rad
Advertisement
Life Technologies